|
SGI-1776市场分析报告
|
Global Market Report of SGI-1776 (CAS 1025065-69-3) December 2024
SuperGen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... various chemotherapy agents and radiation. SGI-1776Pim Kinase Inhibitor: Pim ... The companys Pim kinase inhibitor, SGI-1776, is an orally administered, small molecule ... and pharmacokinetic profile of SGI-1776 in the first half of 2009. SGI-110DNMT1 ...
Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 ... developed, with notable examples including SGI-1776, MEN1703, SGI-1776, ETH-155008, JP11646. These ... . The advancement of some of these such as SGI-1776, ETH-155008 into clinical trials ...
|
|
|